Moderna, Inc. vs United Microelectronics Corp — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while United Microelectronics Corp trades at $21.12 (market cap $51.00B). The key difference: United Microelectronics Corp is far larger — about 2.2× Moderna, Inc.'s market cap, and United Microelectronics Corp pays a 2.03% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | UMC | |
|---|---|---|
Market Cap | $23.60B | $51.00B |
Sector | Health | Technology |
52-Week High | $81.80 | $28.02 |
52-Week Low | $22.36 | $6.58 |
Enterprise Value | $19.70B | $48.57B |
Dividend Yield | — | 2.03% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →